89 related articles for article (PubMed ID: 6279745)
1. [The study for the standard of the remission of the patients with trophoblastic disease (author's transl)].
Katoh T; Endoh N; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Apr; 34(4):511-20. PubMed ID: 6279745
[TBL] [Abstract][Full Text] [Related]
2. [Studies on the recurrent trophoblastic disease].
Takamizawa H; Kobayashi O; Katoh T; Shirotake S; Endou N; Ishige H
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Oct; 34(10):1729-35. PubMed ID: 6294193
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of remission in trophoblastic disease as seen from serum hCG level (author's transl)].
Hirashima N
Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):592-600. PubMed ID: 6263999
[TBL] [Abstract][Full Text] [Related]
4. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
5. [Studies on enzymeimmunoassay for human chorionic gonadotropin and its clinical application].
Kobayashi O; Shirotake S; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jun; 35(6):764-72. PubMed ID: 6308107
[TBL] [Abstract][Full Text] [Related]
6. Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy.
Ngan HY; Wong LC
Chin Med J (Engl); 1999 Mar; 112(3):260-3. PubMed ID: 11593563
[TBL] [Abstract][Full Text] [Related]
7. [The follow-up of trophoblastic disease by using an hCG-CTP enzyme immunoassay].
Matsuura Y; Kashimura M; Shinohara M; Baba S; Kondo M; Kashimura Y
Gan No Rinsho; 1990 Dec; 36(15):2559-62. PubMed ID: 2176247
[TBL] [Abstract][Full Text] [Related]
8. The hCG assay in the treatment of trophoblastic disease.
Pattillo RA; Hussa RO
J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
[TBL] [Abstract][Full Text] [Related]
9. High-dose methotrexate for gestational trophoblastic disease.
Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
[TBL] [Abstract][Full Text] [Related]
11. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
Cole LA; Butler S
J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
[TBL] [Abstract][Full Text] [Related]
12. Human chorionic gonadotropin assays and their uses.
Tyrey L
Obstet Gynecol Clin North Am; 1988 Sep; 15(3):457-75. PubMed ID: 2852329
[TBL] [Abstract][Full Text] [Related]
13. [Results of the treatment of trophoblast tumours (author's transl)].
Tscherne G
Geburtshilfe Frauenheilkd; 1982 May; 42(5):371-5. PubMed ID: 6286404
[TBL] [Abstract][Full Text] [Related]
14. Criteria of complete remission from trophoblastic neoplasia with the use of human chorionic gonadotropin (HCG) excretion pattern as a parameter.
Tomoda Y; Asai Y; Arii Y; Kaseki S; Nishi H; Miwa T; Saiki N; Ishizuka N
Cancer; 1977 Sep; 40(3):1016-25. PubMed ID: 198083
[TBL] [Abstract][Full Text] [Related]
15. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
Wolfberg AJ; Feltmate C; Goldstein DP; Berkowitz RS; Lieberman E
Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
[TBL] [Abstract][Full Text] [Related]
16. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
17. Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.
van Trommel NE; Massuger LF; Schijf CP; ten Kate-Booij MJ; Sweep FC; Thomas CM
J Clin Oncol; 2006 Jan; 24(1):52-8. PubMed ID: 16382113
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
Kohorn EI; Kacinski BM; Stanley ER
Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of beta-subunit chorionic gonadotropin as an aid in diagnosis of trophoblastic disease.
Skinner MS; Seckinger D
Ann Clin Lab Sci; 1979; 9(4):347-52. PubMed ID: 225983
[TBL] [Abstract][Full Text] [Related]
20. [Actual possibilities of prevention and treatment of trophoblastic disease (author's transl)].
Kudela M; Talas M; Fingerová H
Cesk Gynekol; 1981 Mar; 46(2):108-11. PubMed ID: 6263504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
